- Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as …
Počet záznamov: 1  

Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy

  1. SYSr040671
    LBL
      
    ^^^^^naa--2200000-a-4500
    005
      
    20250607120044.6
    008
      
    070308c2006----xo-----e------------engo-
    040
      
    $a BA006 $b slo
    041
    0-
    $a eng $b eng
    044
      
    $a xo $c SK
    080
      
    $a 618.146-006.6-036-076.5-08:615.849:575.113 $2 2.
    242
    10
    $a Strata heterozygotnosti na chromozómoch 2p, 3p, 18q21.3 a 11p15.5 ako prognostický faktor karcinómu krčka maternice štádia II a III (FIGO) liečenej rádioterapiou $y slo
    245
    10
    $a Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy / $c L. Kozlowski ... [et al.]
    300
      
    $b obr., tab.
    504
      
    $a Res. angl.
    504
      
    $a Bibliogr. odkazy
    650
    12
    $7 sllk_us_auth*d002583 $a nádory krčka maternice $x genetika $2 mesh $9 .
    650
    12
    $7 sllk_us_auth*d002294 $a karcinóm skvamocelulárny $x diagnostika $x genetika $x rádioterapia $2 mesh $9 .
    650
    12
    $7 sllk_us_auth*d019656 $a strata heterozygotnosti $2 mesh $9 .
    650
    22
    $7 sllk_us_auth*d011379 $a prognóza $2 mesh $9 .
    650
    22
    $7 sllk_us_auth*d016133 $a reakcia polymerázová reťazová $x využitie $2 mesh $9 .
    650
    22
    $7 sllk_us_auth*d005819 $a markery genetické $2 mesh $9 .
    650
    22
    $7 sllk_us_auth*d013534 $a prežívanie $2 mesh $9 .
    653
    2-
    $a faktor prognostický
    653
    2-
    $a markery mikrosatelitné
    700
    1-
    $7 sllk_us_auth*p0036687 $a Kozlowski, L. $u Department of Oncology, Medical University of Bialystok, Poland $4 aut
    700
    1-
    $7 sllk_us_auth*p0047355 $a Filipowski, T. $u Department of Gynecologic Oncology, Regional Cancer Center in Bialystok, Poland $4 aut
    700
    1-
    $7 sllk_us_auth*p0047356 $a Rucinska, M. $u Department of Oncology, Medical University of Bialystok, Poland $4 aut
    700
    1-
    $7 sllk_us_auth*p0047357 $a Pepinski, W. $u Department of Forensic Medicine, Medical University of Bialystok, Poland $4 aut
    700
    1-
    $7 sllk_us_auth*p0047358 $a Janica, J. $u Department of Forensic Medicine, Medical University of Bialystok, Poland $4 aut
    700
    1-
    $7 sllk_us_auth*p0047359 $a Skawronska, M. $u Department of Forensic Medicine, Medical University of Bialystok, Poland $4 aut
    700
    1-
    $7 sllk_us_auth*p0047360 $a Poznanski, J. $u Department of Gynecologic Oncology, Regional Cancer Center in Bialystok, Poland $4 aut
    700
    1-
    $7 sllk_us_auth*p0036688 $a Wojtukiewicz, M. Z. $u Department of Oncology, Medical University of Bialystok, Poland $4 aut
    773
    0-
    $7 nnas $w sllk_us_cat*sg000148_2006_006_005 $t Neoplasma $f Cancer Research Institute of the Slovak Academy of Sciences $x 0028-2685 $d Bratislava : VEDA, vydavateľstvo Slovenskej akadémie vied $g Vol. 53, no. 5 (2006), s. 440-443
Počet záznamov: 1  

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.